TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/27/21 13:35 | 5/25/21 | MEIP | Mei Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gold Daniel P Phd | CA | DO | CEO | M.d | 13 | 2.52 | 0 | 5 | 1 | 459 | D | ||||||||||||||
7/27/20 13:59 | 7/23/20 | MEIP | Mei Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gold Daniel P Phd | CA | DO | CEO | M.d | 19 | 1.57 | 0 | 12 | 3 | 454 | D | ||||||||||||||
12/20/19 12:54 | 12/19/19 | MEIP | Mei Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gold Daniel P Phd | CA | DO | CEO | P | 30 | 1.60 | 0 | 19 | 5 | 362 | D | ||||||||||||||
10/1/19 12:04 | 9/27/19 | MEIP | Mei Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gold Daniel P Phd | CA | DO | CEO | M.d | 31 | 1.57 | 0 | 20 | 6 | 343 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |